96-5552. Zurich Life Insurance Company of America, et al.; Notice of Application  

  • [Federal Register Volume 61, Number 47 (Friday, March 8, 1996)]
    [Notices]
    [Pages 9513-9515]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-5552]
    
    
    
    -----------------------------------------------------------------------
    
    SECURITIES AND EXCHANGE COMMISSION
    [Rel. No. IC-21800; File No. 812-9922]
    
    
    Zurich Life Insurance Company of America, et al.; Notice of 
    Application
    
    March 4, 1996.
    AGENCY: Securities and Exchange Commission (``SEC'' or ``Commission'').
    
    ACTION: Notice of application for an order under the Investment Company 
    Act of 1940 (the ``1940 Act'').
    
    -----------------------------------------------------------------------
    
    APPLICANTS: Zurich Life Insurance Company of America (``Zurich Life''), 
    Kemper Investors Life Insurance Company (``KILICO''), Federal Kemper 
    Life Assurance Company (``FKLA''), Zurich Life Variable Annuity 
    Separate Account (the ``Account''), and Investors Brokerage Services, 
    Inc. (``IBS'').
    
    RELEVANT 1940 ACT SECTIONS: Order requested under Section 6(c) of the 
    1940 Act for exemptions from Sections 26(a)(2)(C) and 27(c)(2) thereof.
    
    SUMMARY OF APPLICATION: Applicants request an order permitting Zurich 
    Life, KILICO and FKLA to deduct mortality and expense risk charges from 
    the assets of certain separate accounts that fund certain individual 
    deferred variable annuity contracts.
    
    FILING DATE: The application was filed on December 28, 1995.
    
    HEARING OR NOTIFICATION OF HEARING: An order granting the application 
    will be issued unless the Commission orders a hearing. Interested 
    persons may request a hearing by writing to the Secretary of the SEC 
    and serving Applicants with a copy of the request, personally or by 
    mail. Hearing requests must be received by the SEC by 5:30 p.m. on 
    March 29, 1996, and should be accompanied by proof of service on 
    Applicants in the form of an affidavit or, for lawyers, a certificate 
    of service. Hearing requests should state the nature of the writer's 
    interest, the reasons for the request, and the issues contested. 
    Persons may request notification of a hearing by writing to the 
    Secretary of the SEC.
    
    ADDRESSES: Secretary, SEC, 450 Fifth Street, NW., Washington, DC 20549. 
    Applicants, Frank J. Julian, Esq., Kemper Investors Life Insurance 
    Company, KLIC Legal T-1, 1 Kemper Drive, Long Grove, Illinois, 60049.
    
    FOR FURTHER INFORMATION CONTACT: Joseph G. Mari, Senior Special 
    Counsel, or Patrice M. Pitts, Special Counsel, Office of Insurance 
    Products, Division of Investment Management, at (202) 942-0670.
    
    SUPPLEMENTARY INFORMATION: Following is a summary of the application. 
    The complete application is available for a fee from the Public 
    Reference Branch of the Commission.
    
    Applicants' Representations
    
        1. Zurich Life, KILICO, and FKLA (collectively referred to as the 
    ``Companies'') are stock life insurance companies organized under the 
    laws of Illinois. Zurich Life is a wholly-owned subsidiary of Zurich 
    Insurance Company; KILICO is wholly-owned subsidiary of Kemper 
    Financial Corporation (``Kemper''); and FKLA is a wholly-owned 
    subsidiary of Kemper. Zurich Life entered into a definitive agreement 
    to become the majority owner of Kemper, including Kemper's direct and 
    indirect subsidiaries, KILICO and FKLA. Zurich Life is the depositor of 
    the Account.
        2. The Account, established by Zurich Life under Illinois law as an 
    insurance company separate account to fund certain variable annuity 
    contracts (the ``Account Contracts''), is registered under the 1940 Act 
    as a unit investment trust. Applicants request that the relief sought 
    herein extend to variable annuity contracts that are materially similar 
    to the Account Contracts (``Future Contracts'') (the Account Contracts 
    and the Future Contracts collectively referred to as the ``Contracts'') 
    and that are offered by the Account.
        3. The Companies may establish one or more separate accounts in the 
    future (``Other Accounts'') (Other Accounts and the Account are 
    referred to collectively as the ``Separate Accounts'') to support 
    Future Contracts that are offered through any other broker-dealer that 
    (i) may serve in the future as principal underwriter in respect of 
    certain variable annuity contracts offered by the Companies, (ii) is 
    registered under the Securities Exchange Act of 1934 as a broker-dealer 
    and which is or will be a member of the National Association of 
    Securities Dealers, Inc. (the ``NASD''), and (iii) is controlling, 
    controlled by, or under common control with Zurich Life or any other 
    affiliated insurance company (Other Principal Underwriters''). 
    Applicants request that the relief sought herein extend to the Other 
    Accounts.
        4. The Account is comprised of 14 sub-accounts each of which 
    invests in the corresponding portfolio or series of a management 
    investment company registered under the 1940 Act. Zurich Life may 
    create new sub-accounts of the Account.
        5. IBS, a registered broker-dealer and a member of the NASD, is the 
    principal underwriter of the Account Contracts.
        6. The Account Contracts provide retirement payments or other long-
    term benefits for individuals who qualify for federal income tax 
    advantages available under Sections 401, 403(b), 408 and 457 of the 
    Internal Revenue Code of 1986, as amended (``qualified Account 
    Contracts''), and for individuals desiring such benefits who do not 
    qualify for such tax advantages (``non-qualified Account Contracts''). 
    The Account Contracts will be offered on a flexible payment basis.
        7. Applicants state that the minimum initial purchase payment is 
    $50 for a qualified Account Contract and $2,500 for a non-qualified 
    Account Contract. The minimum additional purchase payment for a non-
    qualified Account Contract is $500. However, when purchase payments are 
    made through a systematic investing program and the annual contribution 
    is not less than $600, the minimum payment is $50.
        8. Certain charges and fees are assessed under the Account 
    Contracts. Where applicable, the dollar amount of state premium taxes 
    previously paid or payable upon annuitization by Zurich 
    
    [[Page 9514]]
    Life may be charged against Contract Value (the amount that the Account 
    Contract provides for investment at any time) if not previously 
    assessed, when and if the Account Contract is annuitized. Premium taxes 
    range up to 3.5%.
        9. No front-end sales charge is imposed when purchase payments are 
    applied under the Account Contracts. However, a contingent deferred 
    sales charge (``CDSC'') will be used to cover expenses relating to the 
    sale of the Account Contracts. The maximum CDSC is 6% of the amount 
    withdrawn during the first Contract year. The percentage scales 
    downward by one percent each year, so that there is no charge against 
    accumulation units withdrawn or annuitized in the seventh and later 
    contribution years. Contract owners will be permitted to withdraw up to 
    10% of the Contract Value determined at the time the withdrawal is 
    requested in any Contract year without the assessment of any sales 
    charge. If the Contract owner withdraws an amount in excess of the 10% 
    amount, the excess withdrawn is subject to a CDSC. In no event, will 
    the CDSC under the Account Contracts be greater than 7.25% of purchase 
    payments.
        10. Applicants submit that proceeds from the CDSC may not cover the 
    expected cost of distributing the Account Contracts and that any 
    shortfall will be recovered from Zurich Life's general assets, which 
    may include revenue from the mortality and expense risk charge deducted 
    from the Account.
        11. The administrative charges to be assessed with respect to the 
    Account Contracts will be (i) an annual records maintenance charge of 
    $36 per Contract year, which is deducted from the Contract Value upon 
    surrender of the Account Contract, and which is not assessed during the 
    annuity period, and (ii) an asset-related administration charge at an 
    annual rate of .10%. These charges may be reduced by Zurich Life but 
    may not be increased for outstanding Account Contracts.
        12. Zurich Life and the Account represent that they do not expect 
    that the total revenues from the administrative cost portion of the 
    asset-based charge will be greater than the expected administrative 
    expenses, in conformity with the requirements of Rule 26a-1(b) under 
    the 1940 Act. Applicants represents that they are relying on Rules 26a-
    1 and 6c-8 under the 1940 Act in connection with the imposition of the 
    records maintenance charge under the Account Contract.
        13. Applicants propose to deduct a daily charge for mortality and 
    expense risks from the assets of the Account. With respect to the 
    Account Contracts, Zurich Life will assess the Account with a daily 
    charge for mortality and expense risks at an aggregate annual rate of 
    1.20%. Approximately .85% of the annual charge is allocated to the 
    mortality risks and .35% is allocated to the expense risks.
        14. Applicants represent that Zurich Life will assume a mortality 
    risk by its contractual obligation to pay a death benefit to the 
    beneficiary if the owner, as defined in the Account Contract, dies 
    prior to the annuity date. Applicants assert that the Account Contracts 
    provide a guaranteed death benefit that is the greater of: (a) the 
    Contract Value at the time of death; or (b) the total net amount of 
    purchase payments, reduced by any withdrawals.
        15. Applicants also represent that Zurich Life assumes a mortality 
    risk by its contractual obligation to continue to make annuity payments 
    for the life of the annuitant, as defined in the Account Contract, 
    under annuity options involving life contingencies. This assures each 
    annuitant that neither the annuitant's own longevity nor an improvement 
    in life expectancy generally will have an adverse effect on the annuity 
    payments received under an Account Contract. This relieves the 
    annuitant from the risk of outliving the amounts accumulated for 
    retirement. At the same time, Applicants represent that Zurich Life 
    assumes the risk that annuitants as a group will live a longer time 
    than Zurich Life predicts, which would require Zurich Life to pay out 
    more in annuity income than planned.
        16. In addition to mortality risks, Applicants assert that Zurich 
    Life assumes an expense risk under the Account Contracts because the 
    administrative charges under the Contracts may be insufficient to cover 
    actual administrative expenses.
        17. Applicants represent that if the mortality and expense risk 
    charges assessed against Account assets are insufficient to cover the 
    expenses and costs assumed, the loss will be borne by Zurich Life. If 
    the amount deducted for mortality and expense risk charges proves more 
    than sufficient, the excess will be profit to Zurich Life. Zurich Life 
    anticipates earning a profit from the mortality and expense risk 
    charge.
    
    Applicants' Legal Analysis
    
        1. Applicants request that the Commission, pursuant to Section 6(c) 
    of the 1940 Act, grant exemptions from Sections 26(a)(2)(C) and 
    27(c)(2) thereof to the extent necessary to permit the deduction of a 
    mortality and expense risk charge from the assets of the Separate 
    Accounts which fund the Contracts.
        2. Section 6(c) of the 1940 Act, in relevant part, provides that 
    the Commission may issue an order exempting any person, security or 
    transaction, or any class or classes of persons, securities or 
    transactions, from any provision or provisions of the 1940 Act as may 
    be necessary or appropriate in the public interest and consistent with 
    the protection of investors and the purposes fairly intended by the 
    policy and provisions of the 1940 Act.
        3. Sections 26(a)(C) and 27(c)(2) of the 1940 Act prohibit a 
    registered unit investment trust and any depositor thereof or principal 
    underwriter therefore, from selling periodic payment plan certificates 
    unless the proceeds of all payments (other than sales load) are 
    deposited with a qualified trustee or custodian and held under an 
    agreement that provides that no payment to the depositor or principal 
    underwriter shall be allowed except as a fee, not exceeding such 
    reasonable amount as the Commission may prescribe, for bookkeeping and 
    other administrative services.
        4. Applicants assert that the requested exemptions meet the 
    standards of Section 6(c) of the 1940 Act, and that the terms of the 
    relief requested with respect to the Account Contracts or Future 
    Contracts funded by a Separate Account and distributed by IBS or any 
    Other Principal Underwriter are consistent with the standards set forth 
    in Section 76(c) of the 1940 Act. Applicants state that without the 
    requested future relief, they would have to request and obtain 
    exemptive relief in connection with Account Contracts or Future 
    Contracts to the extent required. Applicants submit that any such 
    additional requests for exemption would present no issues under the 
    1940 Act that have not already been addressed in this application.
        5. Applicants submit that the requested exemptive relief is 
    appropriate in the public interest because it would promote 
    competitiveness in the variable annuity contract market by eliminating 
    the need for Zurich Life and its appropriate affiliates to file 
    redundant exemptive applications, thereby reducing administrative 
    expenses and maximizing the efficient use of resources. The delay and 
    expense involved in having to seek exemptive relief repeatedly would 
    impair the ability of Zurich Life and its appropriate affiliates to 
    take advantage of business opportunities as they arise. If Zurich Life 
    and its appropriate affiliates were required to seek exemptive relief 
    
    [[Page 9515]]
    repeatedly with respect to the issues addressed in this Application, 
    investors would not receive any benefit or additional protection 
    thereby. Indeed, they might be disadvantaged as a result of increased 
    overhead expenses incurred by Zurich Life and its appropriate 
    affiliates. Applicants further submit that, for the same reasons, the 
    requested relief is consistent with the purposes of the 1940 Act and 
    the protection of investors.
        6. Applicants represent that the mortality and expense risk charge 
    of 1.20% is and will be within the range of industry practice for 
    comparable annuity products. Applicants state that this determination 
    is, and for Future Contracts will be, based on their analysis of 
    publicly available information about similar industry practices, taking 
    into consideration such factors as current charge levels and benefits 
    provided, the existence of expense charge guarantees, and guaranteed 
    annuity rates. Zurich Life, KILICO and FKLA undertake to maintain at 
    their home offices, and make available to the Commission upon request, 
    memoranda setting forth in appropriate detail the products analyzed, 
    the methodology, and the results of the analysis relied upon, in making 
    the foregoing determination.
        7. The CDSC may be insufficient to cover all costs relating to the 
    distribution of the Account Contracts. In that event, if a profit is 
    realized from the mortality and expense risk charge, all or a portion 
    of such profit may be offset by distribution expenses not reimbursed by 
    the CDSC. Notwithstanding the foregoing, Applicants have concluded that 
    there is a reasonable likelihood that the proposed distribution 
    financing arrangements will benefit the Separate Accounts and Contract 
    owners. Zurich Life, KILICO and FKLA undertake to maintain at their 
    principal offices, and make available upon request to the Commission 
    and its staff, memoranda setting forth the basis for such conclusion.
        8. Zurich Life, KILICO and FKLA also represent that the Separate 
    Accounts will invest only in an underlying fund that undertakes, in the 
    event it should adopt any plan pursuant to Rule 12b-1 of the 1940 Act 
    to finance distribution expenses, to have such plan formulated and 
    approved by a board of directors, a majority of the members of which 
    are not ``interested persons'' of such fund within the meaning of 
    Section 2(a)(19) of the 1940 Act.
    
    Conclusion
    
        Applicants submit, for the reasons stated herein, that the 
    requested exemptions from Sections 26(a)(2)(C) and 27(c)(2) of the 1940 
    Act--to permit the deduction of a mortality and expense risk charge 
    from Separate Account assets funding the Contracts--meet the standards 
    set out in Section 6(c) of the 1940 Act. Accordingly, Applicants assert 
    that the requested exemptions are necessary or appropriate in the 
    public interest and consistent with the protection of investors and the 
    purposes fairly intended by the policy and provisions of the 1940 Act.
    
        For the Commission, by the Division of Investment Management, 
    pursuant to delegated authority.
    Margaret H. McFarland,
    Deputy Secretary.
    [FR Doc. 96-5552 Filed 3-7-96; 8:45 am]
    BILLING CODE 8010-01-M
    
    

Document Information

Published:
03/08/1996
Department:
Securities and Exchange Commission
Entry Type:
Notice
Action:
Notice of application for an order under the Investment Company Act of 1940 (the ``1940 Act'').
Document Number:
96-5552
Dates:
The application was filed on December 28, 1995.
Pages:
9513-9515 (3 pages)
Docket Numbers:
Rel. No. IC-21800, File No. 812-9922
PDF File:
96-5552.pdf